| Literature DB >> 17585107 |
Harold R Collard1, Bethany B Moore, Kevin R Flaherty, Kevin K Brown, Robert J Kaner, Talmadge E King, Joseph A Lasky, James E Loyd, Imre Noth, Mitchell A Olman, Ganesh Raghu, Jesse Roman, Jay H Ryu, David A Zisman, Gary W Hunninghake, Thomas V Colby, Jim J Egan, David M Hansell, Takeshi Johkoh, Naftali Kaminski, Dong Soon Kim, Yasuhiro Kondoh, David A Lynch, Joachim Müller-Quernheim, Jeffrey L Myers, Andrew G Nicholson, Moisés Selman, Galen B Toews, Athol U Wells, Fernando J Martinez.
Abstract
The natural history of idiopathic pulmonary fibrosis (IPF) has been characterized as a steady, predictable decline in lung function over time. Recent evidence suggests that some patients may experience a more precipitous course, with periods of relative stability followed by acute deteriorations in respiratory status. Many of these acute deteriorations are of unknown etiology and have been termed acute exacerbations of IPF. This perspective is the result of an international effort to summarize the current state of knowledge regarding acute exacerbations of IPF. Acute exacerbations of IPF are defined as acute, clinically significant deteriorations of unidentifiable cause in patients with underlying IPF. Proposed diagnostic criteria include subjective worsening over 30 days or less, new bilateral radiographic opacities, and the absence of infection or another identifiable etiology. The potential pathobiological roles of infection, disordered cell biology, coagulation, and genetics are discussed, and future research directions are proposed.Entities:
Mesh:
Year: 2007 PMID: 17585107 PMCID: PMC2094133 DOI: 10.1164/rccm.200703-463PP
Source DB: PubMed Journal: Am J Respir Crit Care Med ISSN: 1073-449X Impact factor: 21.405